Dice Party Policy

The Critical Patient Journal (RDC) promotes the principles of Open Science, encouraging practices that enhance the transparency, reproducibility, verifiability and responsible reuse of scientific knowledge, in line with international recommendations on research and academic publication.

 

⮚      Data Availability

The DRC encourages the responsible provision of research data that underpin published scientific results, where this is ethically, legally and methodologically possible.

Authors are encouraged to deposit research data, protocols, supplementary materials, data collection tools, analysis codes and other scientific resources in recognized institutional, thematic or open access repositories, promoting their preservation, accessibility, interoperability and reuse, preferably through the use of persistent identifiers (PID), such asDigital Object Identifier (DOI).

Where appropriate, internationally recognised institutional or thematic repositories appropriate to the nature of the data made available may be used.

All manuscripts submitted to the RDC must be accompanied by a Data Availability Statement, a mandatory submission document, in which the authors must indicate:

●        Whether data supporting the results of the study are available;

●        Where they can be consulted;

●        The conditions of access to them;

●        Or, where applicable, the reasons for their unavailability.

In studies that meet the definition of a clinical trial, authors should comply with the recommendations of the International Committee of Medical Journal Editors (ICMJE) regarding the Clinical Trial Data Sharing Statement, where applicable.

Where research data cannot be made available, in whole or in part, authors should provide a reasoned justification, in particular where there are limitations related to:

●        The protection of the privacy and confidentiality of participants;

●        Ethical restrictions arising from opinions of ethics committees;

●        Legal or regulatory restrictions;

●        Contractual or institutional obligations;

●        Intellectual property rights;

●        Data belonging to third parties;

●        Other impediments duly substantiated.

The public availability of data is not a mandatory requirement for publication in the DRC. The Journal privileges transparency in the declaration of the availability of data to the detriment of the obligation to disclose it publicly.

Whenever necessary for the purposes of scientific evaluation, verification of the integrity of the research or clarification of issues raised during the editorial process, the Editorial Team may request from the authors access to the original data, research protocols or other relevant materials, undertaking to respect their confidentiality.

The DRC's Data Sharing Policy is aligned with the principles of Open Science, the FAIR (Findable, Accessible, Interoperable and Reusable) principles, as well as the recommendations of the International Committee of Medical Journal Editors (ICMJE), the Committee on Publication Ethics (COPE) and the EQUATOR Network.

 

⮚      Research Protocols

The RDC encourages authors to make available the research protocols that support the submitted studies, whenever this is ethically, legally and methodologically possible, promoting transparency, reproducibility and critical evaluation of the published research.

Whenever the research protocol is publicly available, authors must indicate its reference, persistent identifier (DOI) or link to the repository where it is deposited.

Any relevant changes made to the protocol after the start of the study should be clearly identified and justified in the manuscript, whenever they may influence the interpretation of the results.

In studies that meet the definition of a clinical trial, authors are encouraged to make the study protocol available and to ensure consistency between the protocol, the clinical trial registry and the published results, in accordance with the recommendations of the International Committee of Medical Journal Editors (ICMJE).

 

⮚      Reproducibility and Complementary Materials

In order to favor the reproducibility and verifiability of published research, it is recommended, whenever possible, to make available the materials necessary for the understanding and replication of the studies, including:

●        Data collection tools;

●        Investigation protocols;

●        Statistical analysis plans;

●        Analysis codes, scripts or developed software;

●        Supplementary materials relevant to the interpretation of the results.

The availability of these resources must comply with the applicable ethical principles, the protection of personal data, intellectual property rights and the legislation in force.

Authors are encouraged to preserve the research data and materials underlying the study for an appropriate period after publication, in accordance with the policies of their respective institutions, funding entities or other applicable legal requirements.

The RDC recognizes that data sharing may not be appropriate in all research contexts, particularly when it involves sensitive information regarding human participants. In these situations, the unavailability of data will not constitute, in itself, a reason for rejection of the manuscript, as long as a clear, reasoned justification is presented and considered acceptable by the Editorial Team.

This policy reflects the RDC's commitment to the principles of Open Science and responsible research, promoting more transparent, verifiable, collaborative and reproducible scientific production.